What does a fractional CIO do for a biotech company?

A fractional CIO provides senior IT executive leadership on a part-time or project basis. For biotech and life sciences companies, this means owning the commercial IT strategy, overseeing CRM and data platform implementations, managing vendor relationships, driving launch readiness, and making CIO-level decisions without the overhead of a full-time executive hire.

When does a biotech company need a fractional CIO?

The most common trigger is an upcoming U.S. product launch, typically when a company is in late Phase 2 or Phase 3 and needs to start building the commercial IT infrastructure. Other triggers include implementing a CRM like Veeva, building a commercial data warehouse, or inheriting a broken IT organization after a leadership change.

We already have a Head of IT. How does Tailwinds Advisory work with our existing team?

Many engagements are alongside an existing IT leader. Tailwinds Advisory operates as a Program Executive, owning a specific large-scale program like a CRM rollout, data platform build, or launch readiness initiative, while your Head of IT continues to run day-to-day operations. In other cases, we partner directly with your IT leader in an advisory capacity, providing strategic guidance, mentorship, and executive support behind the scenes.

What is the difference between a fractional CIO and a Program Executive engagement?

A fractional CIO engagement means Tailwinds Advisory acts as your IT executive, setting strategy, managing the budget, leading vendors, and making decisions across the full IT landscape. A Program Executive engagement is more targeted: Tailwinds Advisory takes executive ownership of a specific large program such as a commercial launch, a data warehouse build, or a CRM implementation, and drives it from strategy through delivery.

What commercial IT systems does Tailwinds Advisory implement?

Tailwinds Advisory delivers the full commercial IT stack for biotech launches: CRM (Veeva and alternatives), Medical Affairs platforms, MLR review systems, Market Access tools, commercial data warehouses, data marts, Master Data Management (MDM), third-party data aggregator integrations, tokenization frameworks, and BI/analytics dashboards.

What types of biotech companies does Tailwinds Advisory work with?

Tailwinds Advisory specializes in late Phase 2 through commercial-stage biotech companies preparing for or executing U.S. product launches. Clients range from pre-commercial rare disease biotechs to commercial-stage specialty pharma companies with 50 to 500 employees.

Omnichannel Strategy and Execution at a Pharma Eyecare & Medical Aesthetics Company

top of page

bottom of page